These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 25815206)

  • 1. Plasma 1-deoxysphingolipids are predictive biomarkers for type 2 diabetes mellitus.
    Othman A; Saely CH; Muendlein A; Vonbank A; Drexel H; von Eckardstein A; Hornemann T
    BMJ Open Diabetes Res Care; 2015; 3(1):e000073. PubMed ID: 25815206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fenofibrate lowers atypical sphingolipids in plasma of dyslipidemic patients: A novel approach for treating diabetic neuropathy?
    Othman A; Benghozi R; Alecu I; Wei Y; Niesor E; von Eckardstein A; Hornemann T
    J Clin Lipidol; 2015; 9(4):568-75. PubMed ID: 26228675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma C20-Sphingolipids predict cardiovascular events independently from conventional cardiovascular risk factors in patients undergoing coronary angiography.
    Othman A; Saely CH; Muendlein A; Vonbank A; Drexel H; von Eckardstein A; Hornemann T
    Atherosclerosis; 2015 May; 240(1):216-21. PubMed ID: 25801014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma 1-deoxysphingolipids are early predictors of incident type 2 diabetes mellitus.
    Mwinyi J; Boström A; Fehrer I; Othman A; Waeber G; Marti-Soler H; Vollenweider P; Marques-Vidal P; Schiöth HB; von Eckardstein A; Hornemann T
    PLoS One; 2017; 12(5):e0175776. PubMed ID: 28472035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disturbed sphingolipid metabolism with elevated 1-deoxysphingolipids in glycogen storage disease type I - A link to metabolic control.
    Hornemann T; Alecu I; Hagenbuch N; Zhakupova A; Cremonesi A; Gautschi M; Jung HH; Meienberg F; Bilz S; Christ E; Baumgartner MR; Hochuli M
    Mol Genet Metab; 2018 Sep; 125(1-2):73-78. PubMed ID: 30037504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered sphingoid base profiles in type 1 compared to type 2 diabetes.
    Wei N; Pan J; Pop-Busui R; Othman A; Alecu I; Hornemann T; Eichler FS
    Lipids Health Dis; 2014 Oct; 13():161. PubMed ID: 25305670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma deoxysphingolipids: a novel class of biomarkers for the metabolic syndrome?
    Othman A; Rütti MF; Ernst D; Saely CH; Rein P; Drexel H; Porretta-Serapiglia C; Lauria G; Bianchi R; von Eckardstein A; Hornemann T
    Diabetologia; 2012 Feb; 55(2):421-31. PubMed ID: 22124606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevation of plasma 1-deoxy-sphingolipids in type 2 diabetes mellitus: a susceptibility to neuropathy?
    Dohrn MF; Othman A; Hirshman SK; Bode H; Alecu I; Fähndrich E; Karges W; Weis J; Schulz JB; Hornemann T; Claeys KG
    Eur J Neurol; 2015 May; 22(5):806-14, e55. PubMed ID: 25623782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipidome as a predictive tool in progression to type 2 diabetes in Finnish men.
    Suvitaival T; Bondia-Pons I; Yetukuri L; Pöhö P; Nolan JJ; Hyötyläinen T; Kuusisto J; Orešič M
    Metabolism; 2018 Jan; 78():1-12. PubMed ID: 28941595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deoxysphingoid bases as plasma markers in diabetes mellitus.
    Bertea M; Rütti MF; Othman A; Marti-Jaun J; Hersberger M; von Eckardstein A; Hornemann T
    Lipids Health Dis; 2010 Aug; 9():84. PubMed ID: 20712864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lowering plasma 1-deoxysphingolipids improves neuropathy in diabetic rats.
    Othman A; Bianchi R; Alecu I; Wei Y; Porretta-Serapiglia C; Lombardi R; Chiorazzi A; Meregalli C; Oggioni N; Cavaletti G; Lauria G; von Eckardstein A; Hornemann T
    Diabetes; 2015 Mar; 64(3):1035-45. PubMed ID: 25277395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of the plasma sphingoid base profile with results from oral glucose tolerance tests in gestational diabetes mellitus.
    Khan A; Hornemann T
    EXCLI J; 2017; 16():497-509. PubMed ID: 28694753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous Androgens and Sex Hormone-Binding Globulin in Women and Risk of Metabolic Syndrome and Type 2 Diabetes.
    Fenske B; Kische H; Gross S; Wallaschofski H; Völzke H; Dörr M; Nauck M; Keevil BG; Brabant G; Haring R
    J Clin Endocrinol Metab; 2015 Dec; 100(12):4595-603. PubMed ID: 26445113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elucidating the chemical structure of native 1-deoxysphingosine.
    Steiner R; Saied EM; Othman A; Arenz C; Maccarone AT; Poad BL; Blanksby SJ; von Eckardstein A; Hornemann T
    J Lipid Res; 2016 Jul; 57(7):1194-203. PubMed ID: 27165858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of 1-Deoxysphingoid Bases and Their
    Wan J; Li J; Bandyopadhyay S; Kelly SL; Xiang Y; Zhang J; Merrill AH; Duan J
    J Agric Food Chem; 2019 Nov; 67(46):12953-12961. PubMed ID: 31638789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HSAN1 mutations in serine palmitoyltransferase reveal a close structure-function-phenotype relationship.
    Bode H; Bourquin F; Suriyanarayanan S; Wei Y; Alecu I; Othman A; Von Eckardstein A; Hornemann T
    Hum Mol Genet; 2016 Mar; 25(5):853-65. PubMed ID: 26681808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic changes in type 2 diabetes are reflected in peripheral blood cells, revealing aberrant cytotoxicity, a viral signature, and hypoxia inducible factor activity.
    van der Pouw Kraan TC; Chen WJ; Bunck MC; van Raalte DH; van der Zijl NJ; van Genugten RE; van Bloemendaal L; Baggen JM; Serné EH; Diamant M; Horrevoets AJ
    BMC Med Genomics; 2015 May; 8():20. PubMed ID: 25956355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1-Deoxysphingolipid synthesis compromises anchorage-independent growth and plasma membrane endocytosis in cancer cells.
    Cordes T; Kuna RS; McGregor GH; Khare SV; Gengatharan J; Muthusamy T; Metallo CM
    J Lipid Res; 2022 Oct; 63(10):100281. PubMed ID: 36115594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic 1-deoxysphingolipids are metabolized by a cytochrome P450-dependent pathway.
    Alecu I; Othman A; Penno A; Saied EM; Arenz C; von Eckardstein A; Hornemann T
    J Lipid Res; 2017 Jan; 58(1):60-71. PubMed ID: 27872144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus.
    Li WD; Fu KF; Li GM; Lian YS; Ren AM; Chen YJ; Xia JR
    World J Gastroenterol; 2015 Aug; 21(32):9607-13. PubMed ID: 26327768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.